Israel Englander Cocrystal Pharma, Inc. Transaction History

Millennium Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.27 - $3.6 $2,849 - $37,998	10,555 New	10,555 $3,000
Q4 2021 Feb 14, 2022	SELL	$0.65 - $1.02 $88,549 - $138,954	-136,230 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.25 $137,592 - $170,287	136,230 New	136,230 $143,000
Q1 2021 May 17, 2021	SELL	$1.3 - $2.35 $27,948 - $50,522	-21,499 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.8 - $2.16 $17,199 - $46,437	21,499 New	21,499 $29,000
Q4 2019 Feb 14, 2020	SELL	$0.39 - $2.05 $5,140 - $27,023	-13,182 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.69 - $2.88 $22,277 - $37,964	13,182 New	13,182 $26,000
Q4 2018 Feb 14, 2019	SELL	$1.6 - $3.68 $514,963 - $1.18 Million	-321,852 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$2.3 - $4.95 $203,398 - $437,748	-88,434 Reduced 21.55%	321,852 $805,000
Q2 2018 Aug 14, 2018	BUY	$1.79 - $6.25 $734,411 - $2.56 Million	410,286 New	410,286 $1.5 Million

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $17.5M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.